Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: Rapid induction of Th1-type cytokines and inducible nitric oxide synthase
A. Weishaupt et al., Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: Rapid induction of Th1-type cytokines and inducible nitric oxide synthase, J IMMUNOL, 165(12), 2000, pp. 7157-7163
High-dose hg administration induces apoptotic death of autoreactive T cells
and is an effective therapy of experimental autoimmune diseases of the ner
vous system. To explore the role of cytokines in Ag-specific immunotherapy,
we analyzed mRNA induction and protein expression for the proinflammatory
cytokines TNF-alpha and IFN-gamma, the anti-inflammatory cytokine IL-10, an
d the cytokine-inducible NO synthase (iNOS) during high-dose Ag therapy of
adoptive transfer experimental autoimmune encephalomyelitis (AT-EAE) in the
Lewis rat. Using semiquantitative and competitive RT-PCR, we found 5- to 6
-fold induction of TNF-alpha mRNA and 3-fold induction of IFN-gamma mRNA in
the spinal cord that occurred within 1 h after i.v. injection of Ag and wa
s accompanied by a 2-fold increase of iNOS mRNA, Both IFN-gamma and iNOS mR
NA remained elevated for at least 6 h, whereas TNF-alpha mRNA was already d
own-regulated 6 h after Ag injection. A comparable time course was found fo
r circulating serum levels of TNF-alpha and IFN-gamma. IL-10 mRNA levels di
d not change significantly following Ag injection, Neutralization of TNF-al
pha by anti-TNF-alpha antiserum in vivo led to a significant decrease in th
e rate of T cell and oligodendrocyte apoptosis induced by high-dose Ag admi
nistration, but did not change the beneficial clinical effect of Ag therapy
. Our data suggest profound activation of proinflammatory but not of anti-i
nflammatory cytokine gene expression by high-dose Ag injection. Functionall
y, TNF-alpha contributes to increased apoptosis of both autoaggressive T ce
lls and oligodendrocytes in the target organ and may thereby play a dual ro
le in this model of Ag-specific therapy of CNS autoimmune diseases.